AKTX
NASDAQ
US
Akari Therapeutics Plc - American Depositary Shares
$4.47
▼ $-0.18
(-3.87%)
Vol 6K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$9.4M
ROE
-68.4%
D/E
9.33
Beta
0.32
52W
$0–$2
Wall Street Consensus
10 analysts · Apr 20263
Strong Buy
6
Buy
1
Hold
0
Sell
0
Strong Sell
90.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 60.0%
Next Report
May 12, 2026
EPS Estimate: $-1.33
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-1.33 | — | — |
| Dec 2025 | $-1.53 | $0.00 | +$1.53 |
| Sep 2025 | $-3.13 | $0.00 | +$3.13 |
| Jun 2025 | $-0.12 | $0.00 | +$0.12 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -$2.9M | -$3.8M | -$3.7M | -$1.9M | -$6.4M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -40.4% | -40.4% | -40.4% | -40.4% | -68.4% | -68.4% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 6.04 | 6.04 | 6.04 | 6.04 | 9.33 | 9.33 |
| Current Ratio | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 |
Key Ratios
ROA (TTM)
-31.9%
P/B
1.4
EPS (TTM)
$0.00
CF/Share
$-15.64
52W High
$1.73
52W Low
$0.22
$0.22
52-Week Range
$1.73
Financial Health
Free Cash Flow
-$2.1M
Net Debt
-$367K
Cash
$2.5M
Total Debt
$2.1M
As of Sep 30, 2025
How does AKTX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
AKTX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.4
▼
45%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
AKTX profitability vs Biotechnology peers
ROE
-68.4%
▼
2%
below
peers
(-67.3%)
vs Peers
vs Industry
In line
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-31.9%
▲
32%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
AKTX financial health vs Biotechnology peers
D/E ratio
9.3
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
0.2
▼
96%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.3
▼
67%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
AKTX fundamentals radar
AKTX
Peer median
Industry
AKTX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
AKTX vs peers: key metrics
Top Holders
Top 5: 8.91%Armistice Capital, LLC
5.95%
$344K
Cresset Asset Management, L…
1.80%
$104K
Warberg Asset Management LLC
0.67%
$39K
Palo Alto Investors Lp
0.32%
$18K
HighTower Advisors, LLC
0.17%
$10K
As of Dec 31, 2025
Latest News
No related news yet